Insider plans sale of 4,546 common shares

A holder of common stock filed a notice of proposed sale under Rule 144, covering 4,546 shares to be sold through Fidelity Brokerage Services LLC on or about 01/22/2026 on the NASDAQ market.

Rhea-AI Filing Summary

A holder of common stock filed a notice of proposed sale under Rule 144, covering 4,546 shares to be sold through Fidelity Brokerage Services LLC on or about 01/22/2026 on the NASDAQ market. The filing lists an aggregate market value of 142,750.68 for these shares and notes that there are 30,627,342 shares of the same class outstanding.

The shares to be sold were acquired as restricted stock vesting compensation from the issuer in multiple tranches between 01/27/2024 and 01/11/2025, including vestings of 558, 557, 558, 1,158, 557, and 1,158 shares. The person on whose behalf the sale is being made represents that they are not aware of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AEHR Form 144 filing disclose?

The Form 144 discloses a planned sale of 4,546 shares of common stock on NASDAQ through Fidelity Brokerage Services LLC, with an aggregate market value of 142,750.68.

When is the planned sale of AEHR shares expected to occur?

The planned sale of 4,546 common shares is listed with an approximate sale date of 01/22/2026 on the NASDAQ exchange.

How were the AEHR shares in the Form 144 acquired?

The shares were acquired through restricted stock vesting from the issuer as compensation on several dates between 01/27/2024 and 01/11/2025.

What is the total market value of the AEHR shares to be sold?

The filing lists an aggregate market value of 142,750.68 for the 4,546 common shares proposed to be sold under Rule 144.

How many AEHR shares are outstanding according to the Form 144?

The Form 144 indicates there are 30,627,342 shares of the relevant class of common stock outstanding.

What representation does the selling person make in the AEHR Form 144?

The person for whose account the securities are to be sold represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/22/2026 - 02:40 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001783244
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AEHR TEST SYSTEMS
SEC File Number	000-22893
Address of Issuer	400 KATO TERRACE FREMONT CALIFORNIA 94539
Phone	5106239400
Name of Person for Whose Account the Securities are To Be Sold	OLIPHANT LAURA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4546	142750.68	30627342	01/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2024	Restricted Stock Vesting	Issuer			558	01/27/2024	Compensation
Common	04/27/2024	Restricted Stock Vesting	Issuer			557	04/27/2024	Compensation
Common	07/27/2024	Restricted Stock Vesting	Issuer			558	07/27/2024	Compensation
Common	10/11/2024	Restricted Stock Vesting	Issuer			1158	10/11/2024	Compensation
Common	10/27/2024	Restricted Stock Vesting	Issuer			557	10/27/2024	Compensation
Common	01/11/2025	Restricted Stock Vesting	Issuer			1158	01/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Laura Oliphant
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)